⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL441758 | 0.73 | — | — | |
| SCHEMBL5053967 | 0.69 | — | — | |
| SCHEMBL717371 | 0.69 | — | — | |
| SCHEMBL6720447 | 0.67 | — | — | |
| SCHEMBL6729208 | 0.67 | — | — | |
| SCHEMBL8427370 | 0.67 | — | — | |
| SCHEMBL5599068 | 0.67 | — | — | |
| SCHEMBL514374 | 0.67 | — | — | |
| SCHEMBL10817925 | 0.67 | — | — | |
| Carbon Dioxide SCHEMBL27411305 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7892449-B2 | Liquid crystal display and manufacturing method of same | DAI NIPPON PRINTING CO., LTD. (JP) | 2011-02-22 | — | — | US | claimed |
| US-7425394-B2 | Liquid crystal display | DAI NIPPON PRINTING CO., LTD. (JP) | 2008-09-16 | — | — | US | claimed |
| US-20070026165-A1 | Liquid crystal display and manufacturing method of same | DAI NIPPON PRINTING CO., LTD. (JP) | 2007-02-01 | — | — | US | claimed |
| US-20050266177-A1 | Liquid crystal display | DAI NIPPON PRINTING CO., LTD. (JP) | 2005-12-01 | — | — | US | claimed |
| EP-0657166-B1 | Combination containing a quinoxaline and a nucleoside | AVENTIS PHARMA GMBH (DE) | 2003-04-09 | — | — | EP | claimed |
| US-6369057-B1 | VIRICIDES, IN PARTICULAR AGAINST RETROVIRUSES, HUMAN IMMUNODEFICIENCY VIRUS (HIV) | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-04-09 | — | — | US | claimed |
| EP-0509398-B1 | Quinoxalines, process for their preparation and their use | AVENTIS PHARMA GMBH (DE) | 2001-09-19 | — | — | EP | claimed |
| US-6265418-B1 | ANTICOAGULANTS | UBE INDUSTRIES, LTD. (JP) | 2001-07-24 | — | — | US | claimed |
| EP-1020467-A1 | N-ACYLAMINO ACID AMIDE COMPOUNDS AND INTERMEDIATES FOR PREPARATION THEREOF | UBE INDUSTRIES LIMITED (JP) | 2000-07-19 | — | — | EP | claimed |
| EP-0977570-A1 | QUINOXALINE IN TRIPLE COMBINATION WITH PROTEASE INHIBITORS AND REVERSE TRANSCRIPTASE INHIBITORS AS MEDICINES FOR TREATING AIDS | BAYER AG (DE) | 2000-02-09 | — | — | EP | claimed |
| WO-1998032442-A1 | QUINOXALINE IN TRIPLE COMBINATION WITH PROTEASE INHIBITORS AND REVERSE TRANSCRIPTASE INHIBITORS AS MEDICINES FOR TREATING AIDS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-07-30 | — | — | WO | claimed |
| WO-1998017656-A1 | A FAMILY OF CANADENSOL TAXANES, THE SEMI-SYNTHETIC PREPARATION AND THERAPEUTIC USE THEREOF | INSTITUTE ARMAND-FRAPPIER (CA) | 1998-04-30 | — | — | WO | claimed |
| EP-0728481-A2 | Use of quinoxaline and protease inhibitors in a composition for the treatment of AIDS and/or HIV infections | BAYER AG (DE) | 1996-08-28 | — | — | EP | claimed |
| US-5480879-A | ANTIBACTERIAL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1996-01-02 | — | — | US | claimed |
| EP-0592868-A1 | Quinolonecarboxylic acids | BAYER AG (DE) | 1994-04-20 | — | — | EP | claimed |
| EP-0591808-A1 | Quinolonecarboxylic acids | BAYER AG (DE) | 1994-04-13 | — | — | EP | claimed |
| EP-0509398-A1 | Quinoxalines, process for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-21 | — | — | EP | claimed |
| US-4911745-A | Containing a phenyl substituted in position 3 of ring | ICI AMERICAS INC. (US) | 1990-03-27 | — | — | US | claimed |
| US-4736055-A | STARING MATERIAL FOR PHOTORESIST POLYMERS | CIBA-GEIGY CORPORATION (US) | 1988-04-05 | — | — | US | claimed |
| US-4154756-A | HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1979-05-15 | — | — | US | claimed |